Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma by Jelena Kresoja-Rakic, Merve Sulemani, Michaela B. Kirschner, Manuel Ronner, Glen Reid, Glen Reid, Steven Kao, Steven Kao, Steven Kao, Beat Schwaller, Walter Weder, Rolf A. Stahel, Emanuela Felley-Bosco

Get full text

Leptospermum extract (QV0) suppresses pleural mesothelioma tumor growth in vitro and in vivo by mitochondrial dysfunction associated apoptosis by Huaikai Shi, Le Zhang, Ta-Kun Yu, Ling Zhuang, Helen Ke, Ben Johnson, Emma Rath, Kenneth Lee, Kenneth Lee, Sonja Klebe, Sonja Klebe, Steven Kao, Steven Kao, Karl Lijun Qin, Hong Ngoc Thuy Pham, Hong Ngoc Thuy Pham, Quan Vuong, Yuen Yee Cheng

Get full text

Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential by Tamkin Ahmadzada, Abhishek Vijayan, Fatemeh Vafaee, Ali Azimi, Glen Reid, Stephen Clarke, Steven Kao, Georges E. Grau, Elham Hosseini-Beheshti

Get full text

CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In S... by Yuen Yee Cheng, Man Lee Yuen, Emma M. Rath, Emma M. Rath, Ben Johnson, Ling Zhuang, Ta-kun Yu, Vesna Aleksova, Anthony Linton, Anthony Linton, Steven Kao, Steven Kao, Candice Julie Clarke, Brian C. McCaughan, Ken Takahashi, Kenneth Lee, Kenneth Lee, Kenneth Lee

Get full text

AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors by Wei Tan, Tarek Meniawy, Steven Kao, Nageshwar Budha, Sophia Frentzas, Hao Zheng, Rang Gao, Ahsan Rizwan, Luz de la Hoz Pedroza

Get full text

Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response by Ben Johnson, Ling Zhuang, Emma M. Rath, Man Lee Yuen, Ngan Ching Cheng, Huaikai Shi, Steven Kao, Glen Reid, Yuen Yee Cheng

Get full text

Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab by Udit Nindra, Adel Shahnam, Samuel Stevens, Abhijit Pal, Adnan Nagrial, Jenny Lee, Po Yee Yip, Tamiem Adam, Michael Boyer, Steven Kao, Victoria Bray

Get full text

Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors by Fabrice Barlesi, Steven Kao, Philippe A Cassier, Hua Fang, Frances Fan, Kathryn Allaire, Shiming Ye, Debra T Chao, William R Henner, Joel S Hayflick, Michael A McDevitt

Get full text

3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies by Huaikai Shi, Emma M. Rath, Ruby C. Y. Lin, Ruby C. Y. Lin, Ruby C. Y. Lin, Kadir Harun Sarun, Candice Julie Clarke, Brian C. McCaughan, Brian C. McCaughan, Helen Ke, Helen Ke, Anthony Linton, Anthony Linton, Anthony Linton, Kenneth Lee, Kenneth Lee, Sonja Klebe, Sonja Klebe, Joanneke Maitz, Joanneke Maitz, Joanneke Maitz, Kedong Song, Yiwei Wang, Yiwei Wang, Steven Kao, Steven Kao, Yuen Yee Cheng

Get full text

The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM) by Man Lee Yuen, Ling Zhuang, Emma M. Rath, Takun Yu, Ben Johnson, Kadir Harun Sarun, Yiwei Wang, Steven Kao, Anthony Linton, Candice Julie Clarke, Brian C. McCaughan, Ken Takahashi, Kenneth Lee, Yuen Yee Cheng

Get full text

Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging by Dannel Yeo, Dannel Yeo, Dannel Yeo, Dannel Yeo, Steven Kao, Steven Kao, Ruta Gupta, Ruta Gupta, Ruta Gupta, Sara Wahlroos, Althea Bastian, Althea Bastian, Althea Bastian, Althea Bastian, Heidi Strauss, Heidi Strauss, Heidi Strauss, Heidi Strauss, Vera Klemm, Vera Klemm, Vera Klemm, Vera Klemm, Prajwol Shrestha, Prajwol Shrestha, Prajwol Shrestha, Prajwol Shrestha, Arturo B. Ramirez, Lillian Costandy, Ryan Huston, Brady S. Gardner, Peter Grimison, Peter Grimison, Jonathan R. Clark, Jonathan R. Clark, Jonathan R. Clark, John E. J. Rasko, John E. J. Rasko, John E. J. Rasko, John E. J. Rasko

Get full text

A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE by Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John, Steven Kao, Genni Newnham, Kenneth O’Byrne, Sagun Parakh, Victoria Bray, Kevin Jasas, Sonia Yip, Stephen Q. Wong, Sarah Ftouni, Jerick Guinto, Sushma Chandrashekar, Stephen Clarke, Nick Pavlakis, Martin R. Stockler, Sarah-Jane Dawson, Benjamin J. Solomon

Get full text

LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC by Marliese Alexander, B.Pharm(Hons), MPH, PhD, Joe Wei, MD, Sagun Parakh, MD, Thomas John, MD, Steven Kao, MD, Adnan Nagrial, MD, Samantha Bowyer, MD, Lydia Warburton, MD, Melissa Moore, MD, Brett G.M. Hughes, MD, Timothy D. Clay, MD, Nick Pavlakis, MD, Benjamin J. Solomon, MD, Malinda Itchins, MD

Get full text

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study by Lauren Julia Brown, Lauren Julia Brown, Lauren Julia Brown, Lauren Julia Brown, Victor Khou, Victor Khou, Victor Khou, Chris Brown, Marliese Alexander, Marliese Alexander, Dasantha Jayamanne, Dasantha Jayamanne, Dasantha Jayamanne, Joe Wei, Lauren Gray, Wei Yen Chan, Wei Yen Chan, Samuel Smith, Susan Harden, Susan Harden, Antony Mersiades, Antony Mersiades, Lydia Warburton, Lydia Warburton, Malinda Itchins, Malinda Itchins, Malinda Itchins, Jenny H. Lee, Jenny H. Lee, Nick Pavlakis, Nick Pavlakis, Nick Pavlakis, Stephen J. Clarke, Stephen J. Clarke, Stephen J. Clarke, Michael Boyer, Michael Boyer, Adnan Nagrial, Adnan Nagrial, Adnan Nagrial, Eric Hau, Eric Hau, Eric Hau, Eric Hau, Ines Pires da Silva, Ines Pires da Silva, Ines Pires da Silva, Steven Kao, Steven Kao, Benjamin Y. Kong, Benjamin Y. Kong, Benjamin Y. Kong, Benjamin Y. Kong

Get full text

Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population by Tamkin Ahmadzada, BE, Wendy A. Cooper, BScMed, M.B.B.S., PhD, FRCPA, Mikaela Holmes, BBiomedSc, Annabelle Mahar, M.B.B.S., FRCPA, Helen Westman, MPH, Anthony J. Gill, MD, FRCPA, Ina Nordman, M.B.B.S., FRACP, M(Med)Sc, Po Yee Yip, MbChB., FRACP, PhD, Abhijit Pal, BSc (Hons), M.B.B.S., FRACP, Rob Zielinski, FRACP, M.B.B.S., Hons, Nick Pavlakis, BSc, M.B.B.S., MMed (Clin Epi), PhD, FRACP, Adnan Nagrial, M.B.B.S., PhD, Dariush Daneshvar, MD, FRCPA, Daniel Brungs, M.B.B.S., MMed (Clin Epi), FRCPA, Deme Karikios, BSc, M.B.B.S., FRACP, PhD, Vesna Aleksova, BMedSc, Juliet Burn, M.B.B.S., FRCPA, MIAC, Rebecca Asher, MSc, Georges E. Grau, MD, PhD, Elham Hosseini-Beheshti, MSc, PhD, Glen Reid, PhD, Stephen Clarke, MD, PhD, FRACP, Steven Kao, BHB, MbChB., PhD, FRACP

Get full text